PATENT CLAIM ANALYSIS

Application Number: 16280704
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-09
Patent Classification: ["514", "560000"]

Abstract:
Nitro oleic acid and related metabolites are agonists of PPAR-γ. Surprisingly, nitro oleic acid is a more potent agonist of PPAR-γ, relative to nitro linoleic acid. Thus, nitro oleic acid and its metabolites, as well as their pharmaceutically acceptable salts and prodrug forms, are candidate therapeutics for the treatment of type-2 diabetes, which results from insulin resistance accompanying the improper functioning of PPAR-γ.

Claim (Index 10):
The pharmaceutical composition of  claim 8 , wherein 10-nitro-octadecenoic acid comprises a single regioisomer.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 99.0
- Lexical Diversity: 1.53191
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13666827', '14244741', '14923265', '12670951', '15629277']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7224039456789296
- 35 USC 102 Novelty (BERT): 0.5231124258143013
- Combined Prediction Score: 0.7024747936924668
- Mean Citation Score: 304.431736
- Max Citation Score: 304.43176
- Similarity Product: 229.71721654746057

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test